Professor Veikko Salomaa
National Institute for Health and Welfare (THL), Helsinki (Finland)
Follow
Contributor content
Journal
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
18 January 2024
Journal
Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: an analysis of 49 cohorts from 11 European countries
17 November 2023
Journal
Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus
20 April 2023
Journal
Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
4 January 2023
Journal
Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients
7 September 2021
Journal
Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
17 January 2021
Journal
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
13 January 2021
Journal
Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis
22 December 2020
Journal
Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
23 August 2020
Journal
Worrisome trends in the incidence of coronary artery disease events among young individuals
1 July 2020
